Article
The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations.
Nature communications - 26 Sept 2022
Ma Fayang, Laster Kyle, Dong Zigang
Abstract excerpt
Knowing the mutation frequency of cancer genes in China is crucial for reducing the global health burden. We integrate the tumor epidemiological statistics with cancer gene mutation rates identified in 11,948 cancer patients to determine their weighted proportions within a Chinese cancer patient cohort. TP53 (51.4%), LRP1B (13.4%), PIK3CA (11.6%), KRAS (11.1%), EGFR (10.6%), and APC (10.5%) are identified as the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
